AstraZeneca Resumes UK Trials Of COVID-19 Vaccine Halted By Patient Illness
AstraZeneca has resumed British clinical trials of its COVID19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday.